Product identity
What it is
Active ingredient or category: Hyaluronan or sodium hyaluronate products
Regulatory classification: Prescription medical-device/drug product category; product status varies
What official sources say
- The ACR/Arthritis Foundation guideline conditionally recommends against hyaluronic acid injections for knee osteoarthritis and strongly recommends against them for hip osteoarthritis.
- Product labeling and professional guidance should be read together.
Safety signal—not a complete warning list: This page does not determine candidacy or predict benefit. Ask about product status, evidence, procedure risks, alternatives, cost, and guideline differences. Always read the current label or source for the exact product.
Questions to take to a clinician or pharmacist
- Is this product cleared or approved for the specific joint and diagnosis?
- What do current guidelines say for this joint?
- What are the procedure risks, expected limits, alternatives, and out-of-pocket costs?
Sources reviewed
Links open the authoritative source. Product labels and guidance can change; verify the current version before relying on any summary.
Review status: This page received an editorial source check on August 3, 2026. No clinician or pharmacist is credited as independently reviewing it. Report a correction.
More in Injections
Corticosteroid joint injections
A licensed professional may discuss a corticosteroid injection for selected diagnosed joint conditions. Product choice, joint, frequency, risks, and expected role require individualized evaluation.
Read source profile